Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ACAD
Recent news which mentions ACAD
< Previous
1
2
3
4
5
6
7
Next >
What 10 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
February 28, 2023
Tickers
ACAD
Tags
Benzinga
ACAD
Market News
From
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Tickers
AAON
ACAD
ACHC
ADUS
Tags
HIMS
UHS
OPRA
From
Benzinga
Earnings Preview For ACADIA Pharmaceuticals
February 24, 2023
Tickers
ACAD
Tags
BZI/EP
Earnings
ACAD
From
Benzinga
Analyst Expectations for ACADIA Pharmaceuticals's Future
January 31, 2023
Tickers
ACAD
Tags
Analyst Ratings
BZI/AAR
Market News
From
Benzinga
Mizuho Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
December 21, 2022
Tickers
ACAD
Tags
BZI/AAR/UPDATE
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Tickers
ACAD
ACDC
AEIS
ANET
Tags
QSR
LSPD
PRTA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Tickers
ABMD
ACAD
AKTX
AMC
Tags
ZYME
TIL
CORZ
From
Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Tickers
ACAD
ADMP
AGEN
ALEC
Tags
Market News
DVAX
MRSN
From
Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers
ACAD
Tags
Market News
FDA PDUFA Date
General
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
Market News
BLUE
BMY
From
Benzinga
ACADIA Pharmaceuticals's Return On Capital Employed Insights
August 29, 2022
Tickers
ACAD
Tags
BZI/ROCE
ACAD
Earnings
From
Benzinga
Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022
Tickers
ACAD
VRTX
Tags
General
Market News
News
From
Benzinga
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers
ACAD
Tags
Analyst Ratings
Markets
Market News
From
Benzinga
NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday
August 09, 2022
Tickers
ACAD
BC
CRSP
MNDY
Tags
Markets
NVDA
Market News
From
Benzinga
ACADIA Pharmaceuticals: Q2 Earnings Insights
August 08, 2022
Tickers
ACAD
Tags
Market News
Earnings
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Tickers
ACAD
AZEK
BALL
BCRX
Tags
FSLR
IRBT
IMCR
From
Benzinga
8 Analysts Have This to Say About ACADIA Pharmaceuticals
August 05, 2022
Tickers
ACAD
Tags
Market News
Benzinga
ACAD
From
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Tickers
ACAD
AKBA
ALDX
AMRX
Tags
MRKR
NBIX
Small Cap
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Tickers
AAWW
ACAD
ARRY
ATI
Tags
LPRO
Market News
OGN
From
Benzinga
Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5
August 05, 2022
Tickers
AAPL
ACAD
COIN
INTC
Tags
NIO
News
PGTRF
From
Benzinga
FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions
August 05, 2022
Tickers
ACAD
Tags
Market News
Trading Ideas
Health Care
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
SYRS
Large Cap
SELB
From
Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Tickers
ACAD
AMGN
AXSM
BGNE
Tags
INCY
AXSM
JNJ
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
DSKYF
News
APLS
From
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Tickers
ABBV
ACAD
ACER
APYX
Tags
Market News
MEIP
ACER
From
Benzinga
Acadia Seeks FDA Approval For Genetic Neurological Disorder Candidate
July 18, 2022
Tickers
ACAD
Tags
General
FDA
Market News
From
Benzinga
Where ACADIA Pharmaceuticals Stands With Analysts
July 11, 2022
Tickers
ACAD
Tags
ACAD
Benzinga
Market News
From
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Tickers
ACAD
ACER
ALV
AMED
Tags
SRNE
NN
LEXX
From
Benzinga
Analysts Try To See Beyond Acadia's Alzheimer's Disease Psychosis
June 21, 2022
Tickers
ACAD
Tags
Analyst Color
Market News
General
From
Benzinga
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today?
June 21, 2022
Tickers
ACAD
Tags
Today's Market
NASDAQ:ACAD
ACAD
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.